137 related articles for article (PubMed ID: 10745087)
1. Morphine-related metabolites differentially activate adenylyl cyclase isozymes after acute and chronic administration.
Eckhardt K; Nevo I; Levy R; Mikus G; Eichelbaum M; Vogel Z
FEBS Lett; 2000 Mar; 470(3):309-14. PubMed ID: 10745087
[TBL] [Abstract][Full Text] [Related]
2. Acute and chronic activation of the mu-opioid receptor with the endogenous ligand endomorphin differentially regulates adenylyl cyclase isozymes.
Nevo I; Avidor-Reiss T; Levy R; Bayewitch M; Vogel Z
Neuropharmacology; 2000 Jan; 39(3):364-71. PubMed ID: 10698002
[TBL] [Abstract][Full Text] [Related]
3. Identity of adenylyl cyclase isoform determines the G protein mediating chronic opioid-induced adenylyl cyclase supersensitivity.
Ammer H; Christ TE
J Neurochem; 2002 Nov; 83(4):818-27. PubMed ID: 12421353
[TBL] [Abstract][Full Text] [Related]
4. Opiate-induced adenylyl cyclase superactivation is isozyme-specific.
Avidor-Reiss T; Nevo I; Saya D; Bayewitch M; Vogel Z
J Biol Chem; 1997 Feb; 272(8):5040-7. PubMed ID: 9030567
[TBL] [Abstract][Full Text] [Related]
5. Inhibition and superactivation of the calcium-stimulated isoforms of adenylyl cyclase: role of Gbetagamma dimers.
Steiner D; Avidor-Reiss T; Schallmach E; Saya D; Vogel Z
J Mol Neurosci; 2005; 27(2):195-203. PubMed ID: 16186630
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of AC-II activity following chronic agonist exposure is modulated by phosphorylation.
Schallmach E; Steiner D; Vogel Z
J Mol Neurosci; 2006; 29(2):115-22. PubMed ID: 16954601
[TBL] [Abstract][Full Text] [Related]
7. Activation of G-proteins by morphine and codeine congeners: insights to the relevance of O- and N-demethylated metabolites at mu- and delta-opioid receptors.
Thompson CM; Wojno H; Greiner E; May EL; Rice KC; Selley DE
J Pharmacol Exp Ther; 2004 Feb; 308(2):547-54. PubMed ID: 14600248
[TBL] [Abstract][Full Text] [Related]
8. Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gbetagamma.
Avidor-Reiss T; Nevo I; Levy R; Pfeuffer T; Vogel Z
J Biol Chem; 1996 Aug; 271(35):21309-15. PubMed ID: 8702909
[TBL] [Abstract][Full Text] [Related]
9. Differential superactivation of adenylyl cyclase isozymes after chronic activation of the CB(1) cannabinoid receptor.
Rhee MH; Nevo I; Avidor-Reiss T; Levy R; Vogel Z
Mol Pharmacol; 2000 Apr; 57(4):746-52. PubMed ID: 10727521
[TBL] [Abstract][Full Text] [Related]
10. Adenylyl cyclase type II activity is regulated by two different mechanisms: implications for acute and chronic opioid exposure.
Schallmach E; Steiner D; Vogel Z
Neuropharmacology; 2006 Jun; 50(8):998-1005. PubMed ID: 16545401
[TBL] [Abstract][Full Text] [Related]
11. Regulation of adenylyl cyclase isozymes on acute and chronic activation of inhibitory receptors.
Nevo I; Avidor-Reiss T; Levy R; Bayewitch M; Heldman E; Vogel Z
Mol Pharmacol; 1998 Aug; 54(2):419-26. PubMed ID: 9687584
[TBL] [Abstract][Full Text] [Related]
12. Chronic morphine-mediated adenylyl cyclase superactivation is attenuated by the Raf-1 inhibitor, GW5074.
Yue X; Varga EV; Stropova D; Vanderah TW; Yamamura HI; Roeske WR
Eur J Pharmacol; 2006 Jul; 540(1-3):57-9. PubMed ID: 16750187
[TBL] [Abstract][Full Text] [Related]
13. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
Noble F; Cox BM
Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
[TBL] [Abstract][Full Text] [Related]
14. Alterations in detergent solubility of heterotrimeric G proteins after chronic activation of G(i/o)-coupled receptors: changes in detergent solubility are in correlation with onset of adenylyl cyclase superactivation.
Bayewitch ML; Nevo I; Avidor-Reiss T; Levy R; Simonds WF; Vogel Z
Mol Pharmacol; 2000 Apr; 57(4):820-5. PubMed ID: 10727531
[TBL] [Abstract][Full Text] [Related]
15. Affinities of dihydrocodeine and its metabolites to opioid receptors.
Schmidt H; Vormfelde Sv; Klinder K; Gundert-Remy U; Gleiter CH; Skopp G; Aderjan R; Fuhr U
Pharmacol Toxicol; 2002 Aug; 91(2):57-63. PubMed ID: 12420793
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes.
Rhee MH; Bayewitch M; Avidor-Reiss T; Levy R; Vogel Z
J Neurochem; 1998 Oct; 71(4):1525-34. PubMed ID: 9751186
[TBL] [Abstract][Full Text] [Related]
17. Morphine-6-glucuronide and morphine: mu-opioid receptor binding and effects on dopamine-sensitive adenylate cyclase in striatum.
Christensen CB; Mørk A; Geisler A
Pharmacol Toxicol; 1991 Nov; 69(5):396-8. PubMed ID: 1666432
[No Abstract] [Full Text] [Related]
18. A6V polymorphism of the human μ-opioid receptor decreases signalling of morphine and endogenous opioids in vitro.
Knapman A; Santiago M; Connor M
Br J Pharmacol; 2015 May; 172(9):2258-72. PubMed ID: 25521224
[TBL] [Abstract][Full Text] [Related]
19. Plasticity of adenylyl cyclase-related signaling sequelae after long-term morphine treatment.
Shy M; Chakrabarti S; Gintzler AR
Mol Pharmacol; 2008 Mar; 73(3):868-79. PubMed ID: 18045853
[TBL] [Abstract][Full Text] [Related]
20. mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.
Yoshimura M; Ikeda H; Tabakoff B
Mol Pharmacol; 1996 Jul; 50(1):43-51. PubMed ID: 8700117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]